Found 513 results
The conflict over measles death counts between CDC leadership and Pennsylvania undermines public health efforts in addre...
Bristol Myers Squibb has paused its CAR-T therapy trials for autoimmunity due to severe side effects, raising questions...
A recent report highlights that disabled workers may face significant health insurance coverage losses as Medicaid work...
The FDA is revisiting its stance on botanical drugs as hurdles persist for clozapine use and pig kidneys emerge as a pot...
While a drug for Angelman syndrome failed in trials, experts believe other experimental therapies may still hold promise...
Key changes to Medicare Advantage plans in Boston are forcing patients, like cancer survivor Eldon Clingan, to seek new...
The Phase 3 trial for Novartis' cardiovascular drug pelacarsen concluded without significant results, impacting its pote...
Updated guidelines from leading headache organizations emphasize new migraine treatments while addressing gaps in patien...
MAHA's efforts to reshape American nutrition encounter hurdles stemming from a declining dietitian workforce.
The NIH's recent proposal to limit the number of grants per researcher has sparked varied responses, highlighting ongoin...
The House is poised to vote on a funding bill that would block Trump's initiative to control federal research grants, ta...
Recent research reveals that Paxlovid, a popular Covid-19 treatment, offers no benefit for long Covid patients compared...
Recent drug pricing agreements expand to additional companies, while Novartis and Bristol Myers suspend cell therapy tri...
Novartis celebrates a significant milestone with its BTK inhibitor for multiple sclerosis, advancing the treatment lands...
A new round of pharmaceutical price cuts has been announced, but crucial details and implications remain unclear.
The trial's deadlock raises significant concerns for mental health professionals, especially in the context of postpartu...
Roivant's new therapy, Lisraya, recently approved by the FDA, offers a non-steroidal option for treating dermatomyositis...
A year after resigning from the CDC, former staff members highlight ongoing issues and advocate for a reformed public he...
The federal autism advisory committee discusses vaccines as potential autism triggers, sparking controversy amidst calls...
AstraZeneca's recent heart disease trial failure underscores the effectiveness of stabilizers over silencers for treatin...